CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Recent trial results suggest that CAR T cells may be superior to standard treatments for B-cell NHL that has not responded or has returned after treatment.

CAR T-Cell therapy for the management of mantle cell lymphoma, Molecular Cancer

Non-viral precision T cell receptor replacement for personalized cell therapy

Adoptive T-cell therapy for Hodgkin lymphoma - ScienceDirect

CAR T Cells: Engineering Immune Cells to Treat Cancer - NCI

Cells, Free Full-Text

JPM, Free Full-Text

The CAR T Cell Story Published in healthbook TIMES Oncology Hematology

Long-term outcomes following CAR T cell therapy: what we know so far

CAR T Cells: Second-Line Treatment Option for NHL? - NCI

Frontiers The pathogenesis, diagnosis, prevention, and treatment of CAR-T cell therapy-related adverse reactions

The next wave of cellular immunotherapies in pancreatic cancer - ScienceDirect